Obesity paradox role in the immunosuppressive treatment of hepatocellular carcinoma

doi:10.3748/wjg.v31.i19.105617

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Sum=0

May 21, 2025 (publication date) through May 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastroenterol. May 21, 2025; 31(19): 105617
Published online May 21, 2025. doi: 10.3748/wjg.v31.i19.105617

Open in New Tab Full Size Figure Download Figure

Figure 1 Mechanism of obesity in the role of immunosuppressants for hepatocellular carcinoma. M1 macrophages: Type 1 macrophages; NK cells: Natural killer cells; PD-1: Programmed Death-1; VEGF: Vascular endothelial growth factor.

Citation: Sierra L, Abu-Hammour MN, Chatterjee A, Simons-Linares CR. Obesity paradox role in the immunosuppressive treatment of hepatocellular carcinoma. World J Gastroenterol 2025; 31(19): 105617
URL: https://www.wjgnet.com/1007-9327/full/v31/i19/105617.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i19.105617